arXiv subjects

Joseph M. Boden

Publications and source records attributed to Joseph M. Boden.

3 recordsLinked to original sources

arXiv2025

Absolute Risk Prediction for Cannabis Use Disorder in Adolescence and Early Adulthood Using Bayesian Machine Learning

Introduction: Substance use disorders (SUDs) have emerged as a pressing public health concern in the United States, with adolescent substance use often leading to SUDs in adulthood. Effective strategies are needed to stem this progression. To help fulfill this need, we developed a novel absolute risk prediction model for cannabis use disorder (CUD) for adolescents or young adults who use cannabis. Methods: We trained a Bayesian machine learning model that provides a personalized CUD absolute risk for adolescents or young adults who use cannabis with data from the National Longitudinal Study of Adolescent to Adult Health. Model performance was assessed using 5-fold cross-validation (CV) with area under the curve (AUC) and ratio of the expected to observed number of cases (E/O). Independent validation of the final model was conducted using two datasets. Results: The proposed model has five risk factors: biological sex, delinquency, and scores on personality traits of conscientiousness, neuroticism, and openness. For predicting CUD risk within five years of first cannabis use, AUC values for the training dataset and two validation datasets were 0.68, 0.64, and 0.75, respectively, and E/O values were 0.95, 0.98, and 1, respectively. This indicates good discrimination and calibration performance of the model. Discussion and Conclusion: The proposed model can aid clinicians in assessing the risk of developing CUD among adolescents and young adults who use cannabis, enabling clinically appropriate interventions.

stat.AP↗

arXiv2025

A Bayesian Learning Model for Joint Risk Prediction of Alcohol and Cannabis Use Disorders

Substance use disorders (SUDs) are a serious public health concern in the United States. Alcohol and cannabis are two of the most widely used substances. For adolescent/youth users of alcohol or cannabis, we propose a joint Bayesian learning model to predict their risks of developing alcohol use disorder (AUD) and cannabis use disorder (CUD) in adulthood based on their personal risk factors. The model is trained on nationally representative longitudinal data from Add Health (n = 12503). It consists of sub-models that predict the two SUDs for three groups of users-those who use alcohol only, cannabis only, and both substances - based on shared as well as unique risk factors. The model comprises of ten predictors. We externally validate the model on two independent datasets. The areas under the receiver operating characteristic curves for AUD and CUD, respectively, are: (a) 0.719 and 0.690 based on 5-fold cross-validation, (b) 0.748 and 0.710 based on validation dataset 1, and (c) 0.650 and 0.750 based on validation dataset 2. A simulation study shows that the proposed joint modeling approach generally performs better than separate univariate modeling of the corresponding dependent outcomes in terms of predictive accuracy. Our model may help in identifying adolescent substance users at high risk of developing SUD in adulthood, who can then be helped with appropriate intervention.

stat.AP↗

arXiv2023

Validation of a Bayesian Learning Model to Predict the Risk for Cannabis Use Disorder

Background: Cannabis use disorder (CUD) is a growing public health problem. Early identification of adolescents and young adults at risk of developing CUD in the future may help stem this trend. A logistic regression model fitted using a Bayesian learning approach was developed recently to predict the risk of future CUD based on seven risk factors in adolescence and youth. A nationally representative longitudinal dataset, Add Health was used to train the model (henceforth referred as Add Health model). Methods: We validated the Add Health model on two cohorts, namely, Michigan Longitudinal Study (MLS) and Christchurch Health and Development Study (CHDS) using longitudinal data from participants until they were approximately 30 years old (to be consistent with the training data from Add Health). If a participant was diagnosed with CUD at any age during this period, they were considered a case. We calculated the area under the curve (AUC) and the ratio of expected and observed number of cases (E/O). We also explored re-calibrating the model to account for differences in population prevalence. Results: The cohort sizes used for validation were 424 (53 cases) for MLS and 637 (105 cases) for CHDS. AUCs for the two cohorts were 0.66 (MLS) and 0.73 (CHDS) and the corresponding E/O ratios (after recalibration) were 0.995 and 0.999. Conclusion: The external validation of the Add Health model on two different cohorts lends confidence to the model's ability to identify adolescent or young adult cannabis users at high risk of developing CUD in later life.

stat.AP↗